Kidney transplant, management of acute and chronic kidney disease, end stage renal disease and renal replacement therapies.
Education and Experience
BA, Austin College 1993; MD, University of Texas Medical Branch 1999; Internship, UNC 1999-2000; Residency, UNC 2000-2002; Nephrology Fellowship, UNC 2002-2004; Visiting Clinical Professor, UNC 2006; Transplant Fellowhip, UNC 2006-2007; Clinical Assistant Professor, UNC 2007-present.
Clinical and Research Interests
Dr. True’s interests and research are immune monitoring in kidney transplant, glomerular disease in transplant, and polyoma virus nephropathy. She is involved in the management of acute and chronic kidney disease patients at the University of North Carolina Hospitals and the Carolina Dialysis Center in Sanford, NC.
Singh HK, Andreoni KA, Madden V, True KA, et al. Presence of Urinary Haufen Accurately Predicts Polyomavirus Nephropathy. Journal of the American Society of Nephrology 2009, 20: 416-427.
True KA, Kozlowski T, Andreoni KA. Prospective Monitoring of Renal Transplant Patients with the ImmuKnow® Assay, CMV PCR and BK PCR in a Campath Rapid Steroid Discontinuation Center. American Transplant Congress, May 30-June 3, 2009, Boston, MA.
True KA, Andreoni KA, Nickeleit V, et al. Screening for BK Virus Nephropathy With Urinary Decoy Cells is Both Sensitive and Cost Effective. American Society of Nephrology Annual Meeting, November 1-4, 2007, San Francisco, CA.